• UN Panel on Access to Medicines: What’s the impact on the pharmaceutical market?

    Following several months of intense discussion and negotiations, the High-Level Panel on Access to Medicines has published its report today. The 15 members of the panel, representing a wide range of experts and stakeholders in the health innovation area, have not found consensus on remedies to change the current IP system for medicines, but agreed…

  • Tax transparency: a means to an end?

                      Today’s corporate tax rules are fiendishly complicated and both governments and businesses alike would benefit from a simpler, more transparent system. For decades, governments globally have aggressively courted foreign investment for its benefits in terms of future job creation and economic growth. Tax incentives are one…

Back to top